注入型ドラッグデリバリーデバイスの世界市場レポート2024

注入型ドラッグデリバリーデバイスの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.8%の年間複合成長率（CAGR）で617億8,000万米ドルに成長すると予想されます。予測期間で予想される成長は、慢性疾患の有病率の増加、注射薬の需要の高まり、重篤な感染症の突然の出現、さまざまな臨床試験段階にある多数の薬剤やワクチンなどの要因に起因すると考えられます。予測期間中に予想される注目すべき動向には、マイクロニードルベースのドラッグデリバリーシステムの開発への注力、自己注射可能なデバイスの研究開発への投資、ウェアラブルデバイスの製造、無針注射システムの生産、以下を含む製品ラインの拡大が含まれます。プレフィルドシリンジ、デバイスのデジタル技術の向上、革新的なデバイスの製造、革新的な自動注射器の製造に重点を置いています。

注入型ドラッグデリバリーデバイス市場は、自己注射デバイスに対する嗜好の高まりによって成長しています。これらの医療機器は、患者が自宅で自己投薬できるようにするもので、無針注射器、自動注射器、ペン注射器、ウェアラブル注射器などがあります。注目すべき例には、Becton, Dickinson and Companyの慢性疾患における薬剤の自己注射用に設計された使い捨て自動注射器BD Physiojectが含まれます。 Abbvie, Inc.、3M、Baxter、Gerresheimer AG、Pfizer Inc.などの企業が自己注射市場に積極的に参加しています。自己注射剤の利点と自己投与に対する意識の高まりにより、そのようなデバイスの需要が高まり、注入型ドラッグデリバリーデバイス市場を推進しています。

注入型ドラッグデリバリーデバイス市場の成長は、慢性疾患の有病率の増加によってさらに加速されています。 注入型ドラッグデリバリーデバイスは、長期間にわたって薬剤を投与し、患者のアドヒアランスを強化し、健康状態を改善するための便利で信頼性の高い方法を提供します。国立バイオテクノロジー情報センター（NCBI）は、世界の慢性疾患人口が大幅に増加し、2050年までに1億4,266万人に達すると予測しています。この有病率の高まりが、注入型ドラッグデリバリーデバイス市場の重要な推進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の注入型ドラッグデリバリーデバイス市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 従来の注射剤
• プレフィルドシリンジ
• 自動注射器
• ペン型注射器
• 世界の注入型ドラッグデリバリーデバイス市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 自己免疫疾患
• ホルモン障害
• 腫瘍学
• 希少疾患
• 疼痛管理
• 呼吸療法
• その他の用途
• 世界の注入型ドラッグデリバリーデバイス市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院と診療所
• 在宅ヘルスケアの設定
• 製薬会社およびバイオテクノロジー会社
• 研究
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の注入型ドラッグデリバリーデバイス市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の注入型ドラッグデリバリーデバイス市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 注入型ドラッグデリバリーデバイス市場の競合情勢
• 注入型ドラッグデリバリーデバイス市場の企業プロファイル
  • Becton, Dickinson and Company
  • Baxter International
  • Gerresheimer AG
  • B. Braun Melsungen AG
  • Catalent, Inc.

第31章 その他の大手および革新的な企業

• SkyePharma PLC
• Antares Pharma
• Pfizer Inc
• GE Healthcare
• Owen Mumford
• Catalent Pharma Solutions
• Philips
• West Pharmaceutical Services, Inc.
• Alkermes
• Schott AG
• UCB
• AstraZeneca
• Johnson &Johnson
• NEARMEDIC PLUS LLC
• Pendant Biosciences

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Injectable drug delivery devices serve multiple routes of drug administration, including intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular.

The primary types of injectable drug delivery devices include conventional injectables, pre-filled syringes, auto-injectors, and pen injectors. Pre-filled syringes come with a fixed needle and contain single-dose vaccines or other medications. These devices find applications in various medical areas such as autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. Injectable drug delivery devices are utilized by a range of end-users, including hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, and others.

The injectable drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides injectable drug delivery devices market statistics, including injectable drug delivery devices industry global market size, regional shares, competitors with injectable drug delivery devices market share, detailed injectable drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the injectable drug delivery devices industry. This injectable drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The injectable drug delivery devices market size has grown strongly in recent years. It will grow from $43.54 billion in 2023 to $47.46 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the historical period can be attributed to the rapid growth in the elderly population, an increase in the number of healthcare facilities, rising healthcare expenditure, growth in biologics, and an increasing awareness of self-administration.

The injectable drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $61.78 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth in the forecast period can be attributed to factors such as the increasing prevalence of chronic diseases, a rising demand for injectable drugs, the sudden emergence of severe infections, and a large number of drugs and vaccines in various clinical trial stages. Notable trends expected in the forecast period include a focus on developing microneedle-based drug delivery systems, investment in the research and development of self-injectable devices, manufacturing of wearable devices, production of needle-free injection systems, expansion of product lines to include prefilled syringes, improvement of digital technology in devices, manufacturing of innovative devices, and emphasis on the production of innovative auto-injectors.

The injectable drug delivery devices market is experiencing growth driven by the increasing preference for self-injection devices. These medical devices enable patients to self-administer medication in a home setting and include needle-free, auto, pen, and wearable injectors. Notable examples include BD Physioject, a disposable auto-injector by Becton, Dickinson, and Company, designed for self-injection of drugs in chronic diseases. Companies such as Abbvie, Inc., 3M, Baxter, Gerresheimer AG, and Pfizer Inc. are actively participating in the self-injections market. The advantages of self-injectables and growing awareness of self-administration contribute to the rising demand for such devices, propelling the injectable drug delivery devices market.

The growth of the injectable drug delivery devices market is further fueled by the increasing prevalence of chronic diseases. Injectable drug delivery devices offer a convenient and reliable method for administering medications over extended periods, enhancing patient adherence and improving health outcomes. The National Center for Biotechnology Information (NCBI) projects a significant increase in the global population with chronic diseases, reaching 142.66 million by 2050. This escalating prevalence is a key driver for the injectable drug delivery devices market.

Manufacturers in the injectable drug delivery devices market are placing emphasis on auto-injectors, fully automated, customizable, and reusable devices. Auto-injectors provide patients with control over injection speed, minimizing pain or discomfort. Unilife Corporation's LISA, a reusable auto-injector, offers features such as Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug warming. The technological advancements and new product launches in injectable drug delivery technology are expected to drive significant market growth.

Major companies in the self-injectable drug delivery devices market are innovating new products with enhanced safety systems to stay competitive. Advanced safety injectable drug delivery devices prioritize safe, effective, and reliable drug delivery subcutaneously or intravenously. West Pharmaceutical Services, Inc. launched the NovaGuard SA Pro Safety System, designed for use with prefilled ISO standard 0.5 mL and 1mL long staked-needle syringes. This safety system focuses on preventing needlestick injuries and incorporates features such as low snap-in force, prevention of pre-activation, low activation force for user comfort, and streamlined assembly. The device design simplifies glass pre-filled syringe assembly, reducing downtime and changeover time.

Major companies operating in the injectable drug delivery devices market report are Becton, Dickinson and Company, Baxter International, Gerresheimer AG, B. Braun Melsungen AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc., GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.

North America was the largest region in the injectable drug delivery devices market in 2023. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the injectable drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Injectable Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on injectable drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for injectable drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The injectable drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Syringes; Injectors And Pump
• 2) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
• 3) By End-user: Hospitals And Clinics; Home Healthcare Settings; Pharmaceutical And Biotechnological Companies; Research Laboratories; Other End Users
• Sub segments: Conventional Injectable Devices; Pre-Filled Syringes; Auto-Injectors; Pen-Injectors; Insulin Pumps; Ambulatory Infusion Devices
• Companies Mentioned: Becton, Dickinson and Company; Baxter International; Gerresheimer AG; B. Braun Melsungen AG; Catalent, Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Injectable Drug Delivery Devices Market Characteristics

3. Injectable Drug Delivery Devices Market Trends And Strategies

4. Injectable Drug Delivery Devices Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Injectable Drug Delivery Devices Market Size and Growth

• 5.1. Global Injectable Drug Delivery Devices Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Injectable Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Injectable Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Injectable Drug Delivery Devices Market Segmentation

• 6.1. Global Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Conventional Injectable
• Pre-filled Syringes
• Auto-injectors
• Pen-injectors
• 6.2. Global Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Autoimmune Diseases
• Hormonal Disorders
• Oncology
• Orphan Diseases
• Pain Management
• Respiratory Therapy
• Other Applications
• 6.3. Global Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Home Healthcare Settings
• Pharmaceutical And Biotechnological Companies
• Research Laboratories
• Other End Users

7. Injectable Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Injectable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Injectable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Injectable Drug Delivery Devices Market

• 8.1. Asia-Pacific Injectable Drug Delivery Devices Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Injectable Drug Delivery Devices Market

• 9.1. China Injectable Drug Delivery Devices Market Overview
• 9.2. China Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Injectable Drug Delivery Devices Market

• 10.1. India Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Injectable Drug Delivery Devices Market

• 11.1. Japan Injectable Drug Delivery Devices Market Overview
• 11.2. Japan Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Injectable Drug Delivery Devices Market

• 12.1. Australia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Injectable Drug Delivery Devices Market

• 13.1. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Injectable Drug Delivery Devices Market

• 14.1. South Korea Injectable Drug Delivery Devices Market Overview
• 14.2. South Korea Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Injectable Drug Delivery Devices Market

• 15.1. Western Europe Injectable Drug Delivery Devices Market Overview
• 15.2. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Injectable Drug Delivery Devices Market

• 16.1. UK Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Injectable Drug Delivery Devices Market

• 17.1. Germany Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Injectable Drug Delivery Devices Market

• 18.1. France Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Injectable Drug Delivery Devices Market

• 19.1. Italy Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Injectable Drug Delivery Devices Market

• 20.1. Spain Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Injectable Drug Delivery Devices Market

• 21.1. Eastern Europe Injectable Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Injectable Drug Delivery Devices Market

• 22.1. Russia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Injectable Drug Delivery Devices Market

• 23.1. North America Injectable Drug Delivery Devices Market Overview
• 23.2. North America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Injectable Drug Delivery Devices Market

• 24.1. USA Injectable Drug Delivery Devices Market Overview
• 24.2. USA Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Injectable Drug Delivery Devices Market

• 25.1. Canada Injectable Drug Delivery Devices Market Overview
• 25.2. Canada Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Injectable Drug Delivery Devices Market

• 26.1. South America Injectable Drug Delivery Devices Market Overview
• 26.2. South America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Injectable Drug Delivery Devices Market

• 27.1. Brazil Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Injectable Drug Delivery Devices Market

• 28.1. Middle East Injectable Drug Delivery Devices Market Overview
• 28.2. Middle East Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Injectable Drug Delivery Devices Market

• 29.1. Africa Injectable Drug Delivery Devices Market Overview
• 29.2. Africa Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Injectable Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Injectable Drug Delivery Devices Market Competitive Landscape
• 30.2. Injectable Drug Delivery Devices Market Company Profiles
  • 30.2.1. Becton, Dickinson and Company
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Baxter International
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Gerresheimer AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. B. Braun Melsungen AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Catalent, Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Injectable Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. SkyePharma PLC
• 31.2. Antares Pharma
• 31.3. Pfizer Inc
• 31.4. GE Healthcare
• 31.5. Owen Mumford
• 31.6. Catalent Pharma Solutions
• 31.7. Philips
• 31.8. West Pharmaceutical Services, Inc.
• 31.9. Alkermes
• 31.10. Schott AG
• 31.11. UCB
• 31.12. AstraZeneca
• 31.13. Johnson & Johnson
• 31.14. NEARMEDIC PLUS LLC
• 31.15. Pendant Biosciences

32. Global Injectable Drug Delivery Devices Market Competitive Benchmarking

33. Global Injectable Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Injectable Drug Delivery Devices Market

35. Injectable Drug Delivery Devices Market Future Outlook and Potential Analysis

• 35.1 Injectable Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Injectable Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Injectable Drug Delivery Devices Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer